News

1 Chronic HBV infection leads to the integration ... Chief Executive Officer of SCG Cell Therapy. "SCG101 is the first TCR-T cell therapy to demonstrate both virologic clearance and tumour ...
What is the current share price of Scentre Group (SCG)? Scentre Group's (SCG) current share price is $3.61. This constitutes a price movement of 1.50% when compared to the share price 7 days ago and ...
SCG Cement and Green Solution, a unit of Siam Cement Group, is continuing to develop low-carbon cement, allocating an additional budget of 1 billion baht amid economic challenges that will slow ...
Part sand hills, part swamp the SCG, one of the world’s premier grounds was used as a rubbish dump in the 1850s and it was only in 1924 that the ground got its modern name. In 1851, it was ...
SINGAPORE, May 8, 2025 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical ... today announced late-breaking clinical data from its Phase 1 trial evaluating SCG101, autologous HBV-specific ...
The results demonstrated that SCG101 led to sustained clearance of serum hepatitis B surface antigen (HBsAg) and HBV-DNA in heavily pre-treated patients with HBV-related HCC. Notably, 94% of patients ...